15:09 , Sep 1, 2017 |  BC Week In Review  |  Financial News

AAT deficiency newco Apic Bio launches

Gene therapy company Apic Bio Inc. (Cambridge, Mass.) launched Aug. 22 with an undisclosed investment from the Alpha-1 Foundation and private investor Ed Krapels, who has alpha-1 antitrypsin ( AAT ; A1AT; SERPINA1) deficiency. The...
22:44 , Aug 22, 2017 |  BC Extra  |  Financial News

AAT deficiency newco Apic Bio launches

Gene therapy company Apic Bio Inc. (Cambridge, Mass.) launched Tuesday with an undisclosed investment from the Alpha-1 Foundation and private investor Ed Krapels, who has alpha-1 antitrypsin ( AAT ; A1AT ; SERPINA1) deficiency. The...